Daniel Henderson

Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells.

Ronald Rodríguez, Eric R. Schuur, Ho Yeong Lim et al. · PubMed · 1997 · 590 citations

Viral Replication, Selective Cytotoxic, Replication Competent Adenovirus +12

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler et al. · The Lancet Oncology · 2019 · 519 citations · Full text

A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.

Theodore L. DeWeese, H. Van der Poel, S. Li et al. · PubMed · 2001 · 386 citations

Translational Medicine, Urology, Radiation Medicine +13

Prostate-specific Antigen Expression Is Regulated by an Upstream Enhancer

Eric R. Schuur, Gail Henderson, Lena A. Kmetec et al. · Journal of Biological Chemistry · 1996 · 312 citations · Full text

Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis

Piet Ost, Barbara Alicja Jereczek‐Fossa, Nicholas van As et al. · European Urology · 2015 · 283 citations

Adaptive Radiotherapy, Urology, Surgical Oncology +6